Thus, our study provides the preliminary results necessary to further study the ability of TRPM2 pharmacologic inhibition to prevent the survival, proliferation, and/or metastasis of breast adenocarcinoma cells. The gene discussed is TRPM2; the disease is breast adenocarcinoma.